Folate (vitamin B9)

Folate is vitamin B9, one of the eight B vitamins, and the cofactor your body uses to build and repair DNA, make red blood cells, and run methylation, the chemical process that switches genes on and off and keeps your nervous system, cardiovascular system, and detox pathways working. Most people meet their needs through food (leafy greens, legumes, liver, fortified grains in countries that fortify), but a meaningful chunk of the population either doesn't eat enough of those, can't convert standard folic acid efficiently due to a common gene variant, or has elevated demand from pregnancy, alcohol, certain medications, or chronic illness.

The two main reasons people supplement are pregnancy (folate dramatically reduces the risk of neural tube defects like spina bifida when taken before and during early pregnancy) and methylation support, where people use the active form (L-methylfolate or 5-MTHF) to help bring down elevated homocysteine, support mood, or work around an MTHFR gene variant. If your homocysteine is high, your diet is light on greens and legumes, you're on a medication that depletes folate (methotrexate, certain anticonvulsants, metformin to a lesser degree), or you're planning a pregnancy, this is one of the most evidence-backed supplements you can take. For everyone else eating a reasonable diet, food usually covers it.

Frank folate deficiency is uncommon in countries that fortify grains (US, Canada, UK, Australia, most of Latin America), more common where they don't (most of Europe, parts of Asia and Africa). The signs to watch for are subtle and overlap with B12 deficiency:

Persistent fatigue, breathlessness on stairs, pale skin, brain fog, the classic megaloblastic anaemia picture, your red blood cells get bigger but carry less oxygen

Sore, smooth, or red tongue (glossitis) and mouth ulcers that won't heal

Low mood, irritability, poor concentration that doesn't track with life circumstances

Tingling or numbness in hands or feet (more often a B12 sign, but folate can contribute)

Elevated MCV on a routine blood test (mean corpuscular volume above 100 fL is the most common incidental finding that prompts testing)

The groups most likely to actually be low even on a decent diet: heavy drinkers, people on methotrexate or antiepileptics (phenytoin, carbamazepine, valproate), people with coeliac disease, IBD, or gastric bypass, women on long-term oral contraceptives, pregnant or breastfeeding women, people eating very low amounts of leafy greens and legumes, and TT homozygotes for the MTHFR C677T variant who run lower folate at the same intake.

If you want to confirm deficiency do bloodwork. Serum folate reflects what you ate in the last few days, RBC folate reflects the last 3-4 months and is the better marker. Pair it with B12, MMA, and homocysteine, since the four together tell a clearer story than any one alone.

Deep-dive

Folate exists in several forms. Dietary folate from food is mostly polyglutamated and gets cleaved in the gut to monoglutamates before absorption. Folic acid is the fully oxidised synthetic form used in supplements and food fortification, it's cheap and stable but biologically inert. To be used, it has to be reduced by dihydrofolate reductase (DHFR) into dihydrofolate, then again into tetrahydrofolate, then methylated into 5-methyltetrahydrofolate (5-MTHF), the active circulating form that crosses the blood-brain barrier and donates methyl groups in one-carbon metabolism. L-methylfolate (also sold as L-5-MTHF, Metafolin, Quatrefolic) skips all those steps, it's the active form ready to use.

The central job of 5-MTHF is to donate a methyl group to homocysteine, converting it back into methionine. Methionine then becomes S-adenosylmethionine (SAMe), the universal methyl donor that methylates DNA, neurotransmitters (serotonin, dopamine, noradrenaline, melatonin), phospholipids, and creatine. When folate is low, homocysteine accumulates, SAMe falls, and methylation across the body slows down. This is why folate status touches mood, cardiovascular risk, fetal development, and DNA stability all at once.

The MTHFR variant. The enzyme methylenetetrahydrofolate reductase (MTHFR) converts the folate cycle's intermediate into 5-MTHF. The common C677T polymorphism reduces enzyme activity by around 35% in heterozygotes (CT, roughly 40-50% of people of European or East Asian descent) and 60-70% in homozygotes (TT, around 10% of the population). Population data from a Polish cohort showed CC, CT, and TT frequencies of 47%, 44%, and 9%, consistent with European and many Asian populations. TT carriers typically have lower serum folate at the same dietary intake and higher homocysteine. They also convert folic acid to 5-MTHF less efficiently, which is the main argument for taking the methylated form directly. A randomised crossover trial in CAD patients homozygous for C677T found oral 5-MTHF produced higher bioavailability than equivalent folic acid regardless of genotype. A 2020 review in the Journal of Clinical Medicine concluded that 5-MTHF supplementation effectively bypasses the MTHFR defect.

Neural tube defects and pregnancy. This is the single most established use. The 1991 MRC Vitamin Study, a randomised trial in 1,817 women with a previous neural tube defect pregnancy, found 4mg/day of folic acid taken periconceptionally cut recurrence by 72% (relative risk 0.28). Subsequent population-level food fortification programs in the US, Canada, and dozens of other countries have produced consistent, large reductions in NTD incidence. The neural tube closes by around day 28 of pregnancy, often before many women know they're pregnant, which is why the recommendation is to start at least one month before trying to conceive and continue through the first trimester. Standard pregnancy dose is 400-800 mcg/day for women with no prior NTD history, 4-5 mg/day for women with a prior affected pregnancy or on antiepileptic drugs.

Cardiovascular and stroke risk. Elevated homocysteine is an independent risk factor for stroke and cardiovascular disease, and folate is the main lever for lowering it. A meta-analysis of 30 RCTs covering 82,334 participants found folic acid supplementation reduced stroke risk by 10% and overall cardiovascular risk by 4%, with the effect concentrated in people with lower baseline folate and no preexisting CVD. An earlier stroke-focused meta-analysis found bigger benefits in regions without folate fortification and in trials longer than three years. The picture is that folate isn't going to dramatically change a low-risk person's outcomes, but if your homocysteine is elevated and your folate status is borderline, normalising both is one of the better-evidenced interventions available.

Mood and depression. Low folate is consistently associated with depression and poor antidepressant response. Papakostas's 2012 trial in adults with SSRI-resistant major depression found 15mg/day of L-methylfolate added to ongoing SSRI treatment produced a 32% response rate versus 15% for placebo, with comparable side effects. 7.5mg/day was no better than placebo, dose matters. This is the basis for prescription Deplin (15mg L-methylfolate, marketed as a medical food for depression). The mechanism is plausible, 5-MTHF feeds SAMe production, which feeds monoamine synthesis. It's not a primary antidepressant, it's an augmentation strategy, and it works better in people whose folate status is borderline or whose MTHFR activity is reduced.

Cognitive ageing. Folate deficiency, often alongside B12 deficiency, contributes to cognitive decline in older adults. The picture is messier with supplementation in well-nourished older adults, where benefits are inconsistent. Where folate gets dangerous in this group is when it's high while B12 is low, an increasingly common pattern in fortified countries. Studies in older adults have linked the combination of high folate (or detectable unmetabolised folic acid) with low B12 to faster cognitive decline and higher anaemia risk. If you're over 60 and considering folate supplementation, check B12 first.

Women across the cycle and life stages. Folate requirements rise sharply during pregnancy (RDA 600 mcg vs 400 mcg) and lactation (500 mcg) because folate goes into rapidly dividing fetal tissues and breast milk. Oral contraceptives modestly lower serum and red blood cell folate, which is one reason some hormonal contraceptives are now coformulated with L-methylfolate. Women with a history of miscarriage, particularly recurrent miscarriage, and women with MTHFR variants are often advised to take 5-MTHF rather than folic acid for the pregnancy attempt, though the evidence that this changes outcomes versus standard folic acid is modest. Perimenopausal and postmenopausal women have no special folate requirement beyond the baseline 400 mcg, but homocysteine tends to rise after menopause as oestrogen falls, and folate plus B12 plus B6 is the standard intervention if it does.

Men, fertility, and sperm. Folate is a methyl donor for DNA synthesis and is heavily used during spermatogenesis. A 2023 meta-analysis found folic acid alone modestly improved sperm motility and IVF-ICSI outcomes, though combined folic acid plus zinc didn't add benefit. A large 2,370-couple trial of 5mg folic acid plus 30mg zinc found no improvement in semen quality or live birth rates in general fertility-seeking couples, suggesting the benefit is concentrated in men with low baseline folate, MTHFR variants, or specific sperm DNA fragmentation issues. A high-dose folic acid study (5mg/day for 6 months) in 30 men with idiopathic infertility found global loss of sperm DNA methylation, which is concerning rather than clearly beneficial. The honest read for men is: if you eat reasonably and your folate is in range, supplementing probably won't move sperm parameters. If you're a TT carrier, have known low folate, or have elevated sperm DNA fragmentation, methylfolate at 400-800 mcg is reasonable. Don't megadose folic acid for fertility.

The unmetabolised folic acid problem. Folic acid relies on DHFR to be converted to active folate, and human DHFR activity is famously slow and variable, especially in the liver. Above about 200-400 mcg of folic acid in a single dose, DHFR gets saturated and unmetabolised folic acid (UMFA) starts circulating in the blood. A NHANES analysis of US adults over 60 detected UMFA in 38% of older adults, often persisting after a fast. UMFA isn't found at any meaningful level in people relying on dietary folate alone, it's specifically a product of synthetic folic acid above what DHFR can handle. The clinical implications are still debated, with proposed links to natural killer cell suppression, accelerated cognitive decline in B12-deficient older adults, and theoretical cancer-promotion effects. The evidence is suggestive, not conclusive. The practical takeaway is that high-dose chronic folic acid (above 1mg/day) is the form most likely to produce UMFA, and 5-MTHF doesn't produce UMFA because it bypasses DHFR entirely. This is the strongest practical argument for picking the methylated form, particularly for chronic use above 400 mcg.

Limitations of the evidence. Most folate research has historically used folic acid because it was cheaper and the patented isomer of 5-MTHF was unavailable. Head-to-head comparisons of long-term outcomes (cancer, mortality, fetal outcomes) between folic acid and 5-MTHF are still relatively limited. The pregnancy data, in particular, is overwhelmingly on folic acid, and while bioavailability work shows 5-MTHF achieves equivalent or higher tissue folate, we don't yet have a large RCT proving 5-MTHF reduces NTDs at the same rate. If you're pregnant or trying, folic acid at standard pregnancy doses is the form with the actual evidence base for NTD prevention, switching to 5-MTHF is reasonable but slightly extrapolated.

Dosage:

Daily maintenance: 400 mcg/day of either folic acid or L-methylfolate (5-MTHF) covers the adult RDA. Use 5-MTHF if you have a known MTHFR variant, elevated homocysteine, are over 50, or want to avoid unmetabolised folic acid buildup. Otherwise either form works at this dose.

Pregnancy preparation and pregnancy: 400-800 mcg/day of folic acid, started at least one month before conception and continued through at least the first trimester. Some practitioners use L-methylfolate at the same dose, particularly for women with MTHFR variants or prior miscarriage history, the bioavailability evidence supports this but the NTD-prevention evidence base is on folic acid

High-risk pregnancy: 4-5 mg/day for women with a previous NTD-affected pregnancy, on antiepileptic medication, with type 1 diabetes, or with malabsorption. This is the dose used in the MRC trial. Use folic acid here because that's what the trial evidence is on, not 5-MTHF

Elevated homocysteine: 400-1000 mcg/day of L-methylfolate alongside vitamin B12 (500-1000 mcg methylcobalamin) and B6 (10-50 mg P5P). Folate alone moves homocysteine but the trio works better. Recheck homocysteine at 3 months

L-methylfolate for depression augmentation: 7.5-15 mg/day. The trial showing benefit used 15 mg/day alongside an ongoing SSRI. This is a high dose, only used under medical supervision and typically with treatment-resistant depression

Older adults (60+): 400 mcg/day, but check B12 first. High folate plus low B12 is the dangerous combination. If B12 is borderline, supplement that first before adding folate

Forms: L-5-MTHF (Quatrefolic glucosamine salt, Metafolin calcium salt) for chronic use, methylation support, or known MTHFR variants. Folic acid at low doses (≤400 mcg) is fine for general use, and is the right choice for pregnancy NTD prevention because that's where the trial evidence sits. Avoid high-dose chronic folic acid (>1 mg/day) unless prescribed

Upper limit: The tolerable upper intake level for folic acid is 1 mg/day from supplements and fortified foods (not counting food folate, which has no UL). 5-MTHF has no formally established UL but 15 mg/day has been used in depression trials without significant safety signals

Timing: Take with or without food, absorption is good either way. Daily dosing is more important than timing

Here's what you can expect:

If you were genuinely deficient, you'll notice the megaloblastic anaemia symptoms (fatigue, breathlessness, pallor, brain fog) start to resolve over weeks as red blood cell production normalises. Most people aren't outright deficient, they're somewhere between adequate and optimal, and at that level folate doesn't produce a noticeable subjective effect day to day. It's a background maintenance nutrient. If you're taking it for elevated homocysteine, you won't feel anything, but your homocysteine number should drop on recheck at 3 months. If you're taking 15mg L-methylfolate for depression augmentation, expect a slow improvement over 4-8 weeks rather than a fast effect, this is consistent with the trial timeline.

If you take folate when your folate is already adequate, your body excretes the excess and nothing meaningful changes. If you take it when you have an undiagnosed B12 deficiency, your blood counts may normalise while neurological damage progresses silently, which is the main reason this vitamin needs to be paired with B12 checks in anyone at risk.

Side effects & risks:

Generally very safe. Folate is water-soluble and excess is excreted in urine. Standard doses (400-800 mcg) are well tolerated by almost everyone. Even high doses (5-15 mg) are tolerated short-to-medium term in the trial literature

Masking B12 deficiency is the one serious risk and applies specifically to folic acid (and to a lesser degree 5-MTHF) in people with undiagnosed low B12. Folate corrects the anaemia of B12 deficiency without correcting the neurological damage, which can progress to permanent peripheral neuropathy, gait problems, and cognitive decline. The masking concern is most relevant for older adults, vegans and vegetarians, people on metformin or proton pump inhibitors, and anyone with malabsorption. Always check B12 (and ideally MMA) before chronic folate supplementation if you're in any of these groups

Unmetabolised folic acid (UMFA) accumulates with high-dose folic acid (above ~200-400 mcg in a single dose). The clinical relevance is debated but the conservative move is to use 5-MTHF for chronic supplementation above 400 mcg or to split folic acid doses

Methylation reactions in sensitive individuals. Some people, especially those with COMT variants or pre-existing anxiety, report agitation, insomnia, irritability, or jitteriness on high-dose methylfolate (1mg+). This is often called over-methylation. Drop the dose, take every other day, or shift to a lower dose with niacin (which can blunt methylation) if it persists

Possible mania or agitation in bipolar patients at high doses (15 mg). Methylfolate is generally avoided as an antidepressant augment in bipolar disorder without mood stabilisation

Cancer concerns are unresolved. Observational and animal data suggest excess folic acid may accelerate growth of existing precancerous lesions (particularly colorectal adenomas) while protecting against initial DNA damage. The practical implication, if any, is to not megadose folic acid chronically if you're over 50 with adenoma history, and to favour 5-MTHF or dietary folate

Drug interactions: methotrexate (folate antagonist, but folic acid or folinic acid is often co-prescribed at 5 mg weekly to mitigate side effects), antiepileptics (phenytoin, carbamazepine, valproate deplete folate and folate can lower their plasma levels, monitor closely), sulfasalazine, trimethoprim, certain chemotherapies. Coordinate with your prescriber

Pregnancy: folic acid 400-800 mcg/day is the standard of care. Don't avoid it on UMFA grounds, the NTD prevention benefit is far larger than the theoretical UMFA concern

Allergic reactions are rare but exist, more often reported with folic acid than 5-MTHF

🩸

Blood markers

Serum folate or red blood cell (RBC) folate, baseline if you're considering supplementation for reasons other than pregnancy. RBC folate reflects 3-4 months of intake and is the better long-term marker. Serum folate reflects recent intake and can be misleadingly high after a folate-rich meal. Most labs flag <2 ng/mL serum or <140 ng/mL RBC as deficient, but optimal is closer to >4 ng/mL serum and >400 ng/mL RBC.

Vitamin B12 and MMA (methylmalonic acid), baseline, always, before chronic folate supplementation. MMA is the more sensitive marker, it rises specifically when B12 is functionally low at the cellular level even if serum B12 looks normal. Critical for older adults, vegans, vegetarians, people on metformin or PPIs, and anyone with GI surgery or autoimmune gastritis. Treat B12 deficiency before or alongside folate, never folate alone.

Homocysteine, baseline if you're supplementing for cardiovascular or methylation reasons. Optimal is <8 µmol/L. Recheck at 3 months on treatment, expect a drop of 20-30% with folate + B12 + B6 combined. Doesn't fall with folate alone if B12 is the limiting nutrient.

MTHFR genotype, optional but useful if you have unexplained elevated homocysteine, recurrent miscarriage, family history of early stroke or DVT, or treatment-resistant depression. Knowing whether you're CC, CT, or TT changes the case for picking 5-MTHF over folic acid.

MCV (mean corpuscular volume) on a CBC, often the first hint of folate or B12 deficiency. MCV >100 fL with otherwise unremarkable bloodwork should trigger folate, B12, and MMA testing.

For someone eating a normal varied diet with no specific reason to supplement, no testing is needed. Testing matters most for women planning pregnancy (folate, B12), people with elevated homocysteine or family CVD history (folate, B12, homocysteine, possibly MTHFR), older adults (B12 first), and anyone using high-dose methylfolate for mood (folate, B12, homocysteine baseline and on-treatment).

Sold as a dietary supplement in most countries without prescription. Prescription L-methylfolate (Deplin) is available in the US as a medical food.